Eligibility Assessment | Weekly trial assessments | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
Demographics, drug use history, CIDI (methamphetamine dependence), MINI (depression, psychotic disorders and mania), DIP (family history of psychotic disorders), RCQ, BCIS, BIS items, SAPAS | x | |||||||||||||
Saliva samples | x | x | x | x | x | x | x | x | x | x | x | x | ||
TLFB for days of methamphetamine use | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
Days of other substance use | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
Adverse events | x | x | x | x | x | x | x | x | x | x | x | x | ||
Concomitant medications | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Concomitant treatment | x | x | x | x | x | x | x | x | x | x | x | x | x | |
SDS | x | x | x | x | x | x | x | x | x | x | x | x | x | |
CEQ | x | x | x | x | x | x | x | x | x | x | x | x | x | |
AWQ | x | x | x | x | x | x | x | x | x | x | x | x | x | |
BPRS items | x | x | x | x | x | x | x | x | x | x | x | x | x | |
WPAI-GH | x | x | x | x | x | x | x | x | x | x | x | x | x | |
EQ-5D-5L | x | x | x | x | x | x | x | x | x | x | x | x | x | |
Health service use and criminal justice involvement | x | x | x | x | x | x | x | x | x | x | x | x | x | |
TSQM | x | x | x |